S
SilicoLife
Designs optimized microorganisms and novel pathways for industrial biotechnology applications, based on computational metabolic engineering and synthetic biology approaches
About SilicoLife
Founded in 2010 by Simon Smith, SilicoLife is a biotechnology company that operates at the intersection of biology and artificial intelligence.
Read full description
The company specializes in the design and optimization of microorganisms and novel biochemical pathways for industrial biotechnology applications. SilicoLife uses its proprietary computational platform to create highly efficient and sustainable bioprocesses for the production of a wide range of bio-based products, including ingredients for the food, nutrition, and dietary supplement sectors.
The company's business model is centered on providing its expertise and technology to large industrial players in the chemical, materials, and synthetic biology industries, helping them to reduce the time and cost of developing new products and processes. By leveraging its advanced computational capabilities, SilicoLife is able to accelerate the design-build-test-learn cycle of metabolic engineering, enabling its clients to bring new products to market faster and more efficiently.
At a glance
- Status
- Operational
- Founded
- 2010
- Headquarters
- Braga, Portugal
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 83.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Innovative Food
- Sector
- Biotech & Life Sciences, Predictive Analytics, Biotechnology, Microbiology, Core AI
- Technology
- Artificial Intelligence, Hardware, Big Data, Deep Tech, Nanotech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Dec 2022 | $11M | $44M | BlueCrow Capital | ↗ |
| GRANTOther financing | Jun 2018 | $55K | — | European Innovation Council | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for SilicoLife is 1K monthly website visits, up 3233.3% over the last three months. SilicoLife's team grew 16% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A1 investor entered at this stage
BlueCrow Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SilicoLife on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SilicoLife’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.